Neurobehavioral assessment in the information age

The elucidation of the human and mouse genomes provides new opportunities for exploring the genetic underpinnings of complex mammalian behaviors. This information also provides new windows into the pathophysiology and treatment of neuropsychiatric diseases. Optimal use of the rapidly escalating numbers of mouse lines engineered for these purposes is hindered, however, by practical and theoretical limitations of common behavioral analyses. New strategies combining automated behavioral monitoring and information technologies are currently under development in both academic and industrial settings. These hold promise, both for improving the throughput of mouse behavioral assessment and for providing new insights into the neurobiology of mammalian behavioral regulation.

[1]  G. Mcclearn.  Genetics and alcoholism simulacra. , 1979, Alcoholism, clinical and experimental research.

[2]  R. Morris,et al.  Place navigation impaired in rats with hippocampal lesions , 1982, Nature.

[3]  A. Green.  Neuropharmacology of serotonin , 1985 .

[4]  R. Lister.  Ethologically-based animal models of anxiety disorders. , 1990, Pharmacology & therapeutics.

[5]  P. Willner.  Behavioural models in psychopharmacology : theoretical, industrial, and clinical perspectives , 1990 .

[6]  H. Teräväinen,et al.  Animal models of parkinsonism. , 1990, Pharmacology & toxicology.

[7]  Ian Q Whishaw,et al.  Of Mice and Mazes: Similarities Between Mice and Rats on Dry Land But Not Water Mazes , 1996, Physiology & Behavior.

[8]  R. Paylor,et al.  The use of null mutant mice to study complex learning and memory processes , 1996, Behavior genetics.

[9]  E. Fisher,et al.  Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment , 1997, Mammalian Genome.

[10]  F. Bloom,et al.  Neuroscience of Addiction , 1998, Neuron.

[11]  R. Wise.  Drug-activation of brain reward pathways. , 1998, Drug and alcohol dependence.

[12]  N. Clayton,et al.  Analysing hippocampal function in transgenic mice: an ethological perspective , 1999, Trends in Neurosciences.

[13]  H. Lipp,et al.  Temporal and spatial adaptation to food restriction in mice under naturalistic conditions , 2000, Behavioural Brain Research.

[14]  Klaus Schughart,et al.  Genome-wide, large-scale production of mutant mice by ENU mutagenesis , 2000, Nature Genetics.

[15]  Jane Stewart,et al.  Stress-induced relapse to heroin and cocaine seeking in rats: a review , 2000, Brain Research Reviews.

[16]  S. Prusiner,et al.  Transgenic models of prion disease. , 2000, Archives of virology. Supplementum.

[17]  Janan T. Eppig,et al.  A mouse phenome project , 2000, Mammalian Genome.

[18]  P. Nolan,et al.  Towards new models of disease and physiology in the neurosciences: the role of induced and naturally occurring mutations. , 2000, Human molecular genetics.

[19]  J. Antel,et al.  Genetic models for CNS inflammation , 2001, Nature Medicine.

[20]  I. Liberzon,et al.  Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders , 2001, Psychopharmacology.

[21]  E. Nestler,et al.  Molecular basis of long-term plasticity underlying addiction , 2001, Nature Reviews Neuroscience.

[22]  Richard Paylor,et al.  The use of behavioral test batteries: Effects of training history , 2001, Physiology & Behavior.

[23]  R. Gerlai.  Behavioral tests of hippocampal function: simple paradigms complex problems , 2001, Behavioural Brain Research.

[24]  R. D'Hooge,et al.  Applications of the Morris water maze in the study of learning and memory , 2001, Brain Research Reviews.

[25]  T. Steckler,et al.  The fallacy of behavioral phenotyping without standardisation , 2002, Genes, brain, and behavior.

[26]  G. Dell’Omo,et al.  Early behavioural changes in mice infected with BSE and scrapie: automated home cage monitoring reveals prion strain differences , 2002, The European journal of neuroscience.

[27]  Ole A. Andreassen,et al.  Therapeutic Effects of Coenzyme Q10 and Remacemide in Transgenic Mouse Models of Huntington's Disease , 2002, The Journal of Neuroscience.

[28]  R. Gerlai.  Phenomics: fiction or the future? , 2002, Trends in Neurosciences.

[29]  Neurobiology of Depression , 2002, Neuron.

[30]  Athina Markou,et al.  Assessing antidepressant activity in rodents: recent developments and future needs. , 2002, Trends in pharmacological sciences.

[31]  Rüdiger Klein,et al.  Long‐term monitoring of hippocampus‐dependent behavior in naturalistic settings: Mutant mice lacking neurotrophin receptor TrkB in the forebrain show spatial learning but impaired behavioral flexibility , 2002, Hippocampus.

[32]  Eric Nestler,et al.  In need of high-throughput behavioral systems. , 2002, Drug discovery today.

[33]  E. Gould,et al.  Preclinical models: status of basic research in depression , 2002, Biological Psychiatry.

[34]  L. Tecott.  The genes and brains of mice and men. , 2003, The American journal of psychiatry.

[35]  Douglas Wahlsten,et al.  In search of a better mouse test , 2003, Trends in Neurosciences.

[36]  David W. Self,et al.  Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour , 2003, Nature.

[37]  S. Tabrizi,et al.  Mouse models as a tool for understanding neurodegenerative diseases , 2003, Current opinion in neurology.

[38]  G. Bates,et al.  Experimental therapeutics in Huntington's disease: are models useful for therapeutic trials? , 2003, Current opinion in neurology.

[39]  G. Griebel,et al.  The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic. , 2003, European journal of pharmacology.

[40]  H. Rauvala,et al.  Behavioral alterations induced by repeated testing in C57BL/6J and 129S2/Sv mice: implications for phenotyping screens , 2004, Genes, brain, and behavior.

[41]  R. Lister.  The use of a plus-maze to measure anxiety in the mouse , 2004, Psychopharmacology.

[42]  Bringing natural behaviors into the laboratory : a tribute to Paul MacLean , 2005 .